Connecticut seeks approval to make generic GLP-1 alternative

NBC Connecticut – Tuesday, July 22, 2025
By Mike Savino

Consumers are the only ones struggling to pay the rising prices of popular GLP-1 drugs, as states like Connecticut see skyrocketing costs.

After spending a combined $103 million in fiscal year 2024, the state is estimated to dole out $150 million through Medicaid and another $60 million for state employee insurance plans for the drug.

Click here to read the entire article.